Description
DrugCard provides comprehensive AI-powered solutions designed to enhance pharmacovigilance processes, focusing on automated literature screening and regulatory intelligence. The platform aims to address the increasing pressures faced by the pharmaceutical industry, including AI-driven competition, rapid technological changes, heightened regulatory scrutiny, rising personnel costs, and the complexities of entering new markets.
Read More
By leveraging AI and automation, DrugCard enables continuous, traceable, accurate, and scalable literature monitoring. It supports over 100 languages and covers more than 2200 medical journals, including local publications, ensuring a holistic approach to drug safety. This capability is particularly valuable for managing global and regional requirements, offering CAPEX-free and cost-effective investments.
The solution is designed to benefit various stakeholders within the pharmaceutical ecosystem. Contract Research Organizations (CROs) can improve their screening results and manage more projects efficiently, ensuring compliance for their pharmaceutical clients. Marketing Authorization Holders (MAHs) can upgrade their in-house literature screening practices, moving away from manual methods that are becoming increasingly inefficient and risky. Freelancers offering literature screening services can significantly free up their time, allowing them to focus on higher-value activities like consulting and research, thereby increasing productivity and revenue.
DrugCard's platform is built on advanced OCR technology, capable of achieving up to 99% accuracy on average quality scanned texts, even from imperfectly scanned hard copies. The system provides instant email notifications for new drug mentions and offers weekly summary reports, which are crucial for audits and regulatory inspections. The onboarding process for new countries and journals typically takes 2-3 weeks, with a proven track record of adding 100 custom journals in one month.
Testimonials from users highlight significant time savings, increased productivity, and improved accuracy in capturing information. Users report being able to focus on critical tasks such as signal detection, PSURs, and RMPs, rather than spending excessive time reading articles manually. DrugCard positions itself as a superior alternative to manual screening, promising three to five times more hits discovered and 50-70% time savings.
- CategoryMedical & Clinical AI
- Pricing ModelContact sales
- DeploymentCloud
- PlatformsWeb
DrugCard: Pharmacovigilance Solutions's Core Features
AI-powered literature screening
Automated regulatory intelligence
Adverse event management support
Multi-language literature monitoring (100+ languages supported)
Global and local journal coverage (2200+ journals)
Proprietary OCR technology for scanned texts
Instant email notifications for new drug mentions
Weekly summary reports for audits
Scalable to new markets
Traceable and transparent data
Cost-effective investment
Time savings of 50-70% compared to manual methods
Up to 99% accuracy on scanned texts
How to use DrugCard: Pharmacovigilance Solutions?
Configure: Define search keywords, target languages, and regions.
Monitor: DrugCard automatically screens global and local literature.
Receive Notifications: Get instant alerts for new drug mentions.
Review Reports: Access weekly summary reports for compliance.
Integrate: Utilize insights for signal detection and risk assessment.
Optimize: Refine search parameters based on findings.
DrugCard: Pharmacovigilance Solutions's Use Cases
- Automated Literature Monitoring
- Regulatory Intelligence
- Adverse Event Management
- CRO Efficiency Improvement
- MAH In-house Screening
- Freelancer Productivity Boost
- Multi-language Data Processing
- New Market Entry Support
